There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Drugs. This report contains market size and forecasts of Colorectal Cancer Drugs in global, including the following market information:
Global Colorectal Cancer Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Colorectal Cancer Drugs Market Sales, 2018-2023, 2024-2030, (Units)
Global top five Colorectal Cancer Drugs companies in 2022 (%)
The global Colorectal Cancer Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Drugs include AB Science, Amgen, Array BioPharma, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Elli Lilly, Roch and Hutchison MediPharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colorectal Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Colorectal Cancer Drugs Market Segment Percentages, by Type, 2022 (%)
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Global Colorectal Cancer Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Colorectal Cancer Drugs Market Segment Percentages, by Application, 2022 (%)
Radiotherapy
Chemotherapy
Global Colorectal Cancer Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Colorectal Cancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Colorectal Cancer Drugs revenues share in global market, 2022 (%)
Key companies Colorectal Cancer Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Colorectal Cancer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colorectal Cancer Drugs, market overview.
Chapter 2: Global Colorectal Cancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Colorectal Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Colorectal Cancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Drugs Overall Market Size
2.1 Global Colorectal Cancer Drugs Market Size: 2022 VS 2030
2.2 Global Colorectal Cancer Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Colorectal Cancer Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Colorectal Cancer Drugs Players in Global Market
3.2 Top Global Colorectal Cancer Drugs Companies Ranked by Revenue
3.3 Global Colorectal Cancer Drugs Revenue by Companies
3.4 Global Colorectal Cancer Drugs Sales by Companies
3.5 Global Colorectal Cancer Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Colorectal Cancer Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Colorectal Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Colorectal Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Colorectal Cancer Drugs Market Size Markets, 2022 & 2030
4.1.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
4.1.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
4.1.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
4.1.5 BRAF or MEK Inhibitors
4.1.6 Tyrosine Kinase (TKI) Inhibitors
4.1.7 Immunomodulators
4.2 By Type - Global Colorectal Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Colorectal Cancer Drugs Revenue, 2024-2030
4.2.3 By Type - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Colorectal Cancer Drugs Sales & Forecasts
4.3.1 By Type - Global Colorectal Cancer Drugs Sales, 2018-2023
4.3.2 By Type - Global Colorectal Cancer Drugs Sales, 2024-2030
4.3.3 By Type - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Colorectal Cancer Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Drugs Market Size, 2022 & 2030
5.1.2 Radiotherapy
5.1.3 Chemotherapy
5.2 By Application - Global Colorectal Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Colorectal Cancer Drugs Revenue, 2024-2030
5.2.3 By Application - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Colorectal Cancer Drugs Sales & Forecasts
5.3.1 By Application - Global Colorectal Cancer Drugs Sales, 2018-2023
5.3.2 By Application - Global Colorectal Cancer Drugs Sales, 2024-2030
5.3.3 By Application - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Colorectal Cancer Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Drugs Market Size, 2022 & 2030
6.2 By Region - Global Colorectal Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Colorectal Cancer Drugs Revenue, 2024-2030
6.2.3 By Region - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Colorectal Cancer Drugs Sales & Forecasts
6.3.1 By Region - Global Colorectal Cancer Drugs Sales, 2018-2023
6.3.2 By Region - Global Colorectal Cancer Drugs Sales, 2024-2030
6.3.3 By Region - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Colorectal Cancer Drugs Revenue, 2018-2030
6.4.2 By Country - North America Colorectal Cancer Drugs Sales, 2018-2030
6.4.3 US Colorectal Cancer Drugs Market Size, 2018-2030
6.4.4 Canada Colorectal Cancer Drugs Market Size, 2018-2030
6.4.5 Mexico Colorectal Cancer Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Colorectal Cancer Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Colorectal Cancer Drugs Sales, 2018-2030
6.5.3 Germany Colorectal Cancer Drugs Market Size, 2018-2030
6.5.4 France Colorectal Cancer Drugs Market Size, 2018-2030
6.5.5 U.K. Colorectal Cancer Drugs Market Size, 2018-2030
6.5.6 Italy Colorectal Cancer Drugs Market Size, 2018-2030
6.5.7 Russia Colorectal Cancer Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Colorectal Cancer Drugs Market Size, 2018-2030
6.5.9 Benelux Colorectal Cancer Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Colorectal Cancer Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Colorectal Cancer Drugs Sales, 2018-2030
6.6.3 China Colorectal Cancer Drugs Market Size, 2018-2030
6.6.4 Japan Colorectal Cancer Drugs Market Size, 2018-2030
6.6.5 South Korea Colorectal Cancer Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Colorectal Cancer Drugs Market Size, 2018-2030
6.6.7 India Colorectal Cancer Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Colorectal Cancer Drugs Revenue, 2018-2030
6.7.2 By Country - South America Colorectal Cancer Drugs Sales, 2018-2030
6.7.3 Brazil Colorectal Cancer Drugs Market Size, 2018-2030
6.7.4 Argentina Colorectal Cancer Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Colorectal Cancer Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Colorectal Cancer Drugs Sales, 2018-2030
6.8.3 Turkey Colorectal Cancer Drugs Market Size, 2018-2030
6.8.4 Israel Colorectal Cancer Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Colorectal Cancer Drugs Market Size, 2018-2030
6.8.6 UAE Colorectal Cancer Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 AB Science
7.1.1 AB Science Company Summary
7.1.2 AB Science Business Overview
7.1.3 AB Science Colorectal Cancer Drugs Major Product Offerings
7.1.4 AB Science Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AB Science Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Colorectal Cancer Drugs Major Product Offerings
7.2.4 Amgen Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Array BioPharma
7.3.1 Array BioPharma Company Summary
7.3.2 Array BioPharma Business Overview
7.3.3 Array BioPharma Colorectal Cancer Drugs Major Product Offerings
7.3.4 Array BioPharma Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Array BioPharma Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Colorectal Cancer Drugs Major Product Offerings
7.4.4 Bayer Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Elli Lilly
7.7.1 Elli Lilly Company Summary
7.7.2 Elli Lilly Business Overview
7.7.3 Elli Lilly Colorectal Cancer Drugs Major Product Offerings
7.7.4 Elli Lilly Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Elli Lilly Key News & Latest Developments
7.8 Roch
7.8.1 Roch Company Summary
7.8.2 Roch Business Overview
7.8.3 Roch Colorectal Cancer Drugs Major Product Offerings
7.8.4 Roch Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Roch Key News & Latest Developments
7.9 Hutchison MediPharma
7.9.1 Hutchison MediPharma Company Summary
7.9.2 Hutchison MediPharma Business Overview
7.9.3 Hutchison MediPharma Colorectal Cancer Drugs Major Product Offerings
7.9.4 Hutchison MediPharma Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Hutchison MediPharma Key News & Latest Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Company Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Major Product Offerings
7.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Merck & Co., Inc. Key News & Latest Developments
7.11 Mologen
7.11.1 Mologen Company Summary
7.11.2 Mologen Colorectal Cancer Drugs Business Overview
7.11.3 Mologen Colorectal Cancer Drugs Major Product Offerings
7.11.4 Mologen Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Mologen Key News & Latest Developments
7.12 Regeneron
7.12.1 Regeneron Company Summary
7.12.2 Regeneron Colorectal Cancer Drugs Business Overview
7.12.3 Regeneron Colorectal Cancer Drugs Major Product Offerings
7.12.4 Regeneron Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Regeneron Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Colorectal Cancer Drugs Business Overview
7.13.3 Sanofi Colorectal Cancer Drugs Major Product Offerings
7.13.4 Sanofi Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 Sumitomo Dainippon
7.14.1 Sumitomo Dainippon Company Summary
7.14.2 Sumitomo Dainippon Business Overview
7.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Major Product Offerings
7.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Sumitomo Dainippon Key News & Latest Developments
7.15 Taiho Pharmaceutical
7.15.1 Taiho Pharmaceutical Company Summary
7.15.2 Taiho Pharmaceutical Business Overview
7.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Major Product Offerings
7.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Taiho Pharmaceutical Key News & Latest Developments
7.16 Vaccinogen
7.16.1 Vaccinogen Company Summary
7.16.2 Vaccinogen Business Overview
7.16.3 Vaccinogen Colorectal Cancer Drugs Major Product Offerings
7.16.4 Vaccinogen Colorectal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Vaccinogen Key News & Latest Developments
8 Global Colorectal Cancer Drugs Production Capacity, Analysis
8.1 Global Colorectal Cancer Drugs Production Capacity, 2018-2030
8.2 Colorectal Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Colorectal Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Colorectal Cancer Drugs Supply Chain Analysis
10.1 Colorectal Cancer Drugs Industry Value Chain
10.2 Colorectal Cancer Drugs Upstream Market
10.3 Colorectal Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Colorectal Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Colorectal Cancer Drugs in Global Market
Table 2. Top Colorectal Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Colorectal Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Colorectal Cancer Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Colorectal Cancer Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Colorectal Cancer Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Colorectal Cancer Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Colorectal Cancer Drugs Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Colorectal Cancer Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Colorectal Cancer Drugs Sales (Units), 2024-2030
Table 16. By Application ? Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Colorectal Cancer Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Colorectal Cancer Drugs Sales (Units), 2024-2030
Table 21. By Region ? Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Colorectal Cancer Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Colorectal Cancer Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Colorectal Cancer Drugs Sales (Units), 2024-2030
Table 26. By Country - North America Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Colorectal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Colorectal Cancer Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Colorectal Cancer Drugs Sales, (Units), 2024-2030
Table 30. By Country - Europe Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Colorectal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Colorectal Cancer Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Colorectal Cancer Drugs Sales, (Units), 2024-2030
Table 34. By Region - Asia Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Colorectal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Colorectal Cancer Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Colorectal Cancer Drugs Sales, (Units), 2024-2030
Table 38. By Country - South America Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Colorectal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Colorectal Cancer Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Colorectal Cancer Drugs Sales, (Units), 2024-2030
Table 42. By Country - Middle East & Africa Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Colorectal Cancer Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Colorectal Cancer Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Colorectal Cancer Drugs Sales, (Units), 2024-2030
Table 46. AB Science Company Summary
Table 47. AB Science Colorectal Cancer Drugs Product Offerings
Table 48. AB Science Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AB Science Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Colorectal Cancer Drugs Product Offerings
Table 52. Amgen Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Array BioPharma Company Summary
Table 55. Array BioPharma Colorectal Cancer Drugs Product Offerings
Table 56. Array BioPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Array BioPharma Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Colorectal Cancer Drugs Product Offerings
Table 60. Bayer Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Colorectal Cancer Drugs Product Offerings
Table 64. Boehringer Ingelheim Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Colorectal Cancer Drugs Product Offerings
Table 68. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Elli Lilly Company Summary
Table 71. Elli Lilly Colorectal Cancer Drugs Product Offerings
Table 72. Elli Lilly Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Elli Lilly Key News & Latest Developments
Table 74. Roch Company Summary
Table 75. Roch Colorectal Cancer Drugs Product Offerings
Table 76. Roch Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Roch Key News & Latest Developments
Table 78. Hutchison MediPharma Company Summary
Table 79. Hutchison MediPharma Colorectal Cancer Drugs Product Offerings
Table 80. Hutchison MediPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Hutchison MediPharma Key News & Latest Developments
Table 82. Merck & Co., Inc. Company Summary
Table 83. Merck & Co., Inc. Colorectal Cancer Drugs Product Offerings
Table 84. Merck & Co., Inc. Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Merck & Co., Inc. Key News & Latest Developments
Table 86. Mologen Company Summary
Table 87. Mologen Colorectal Cancer Drugs Product Offerings
Table 88. Mologen Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Mologen Key News & Latest Developments
Table 90. Regeneron Company Summary
Table 91. Regeneron Colorectal Cancer Drugs Product Offerings
Table 92. Regeneron Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Regeneron Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Colorectal Cancer Drugs Product Offerings
Table 96. Sanofi Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Sanofi Key News & Latest Developments
Table 98. Sumitomo Dainippon Company Summary
Table 99. Sumitomo Dainippon Colorectal Cancer Drugs Product Offerings
Table 100. Sumitomo Dainippon Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Sumitomo Dainippon Key News & Latest Developments
Table 102. Taiho Pharmaceutical Company Summary
Table 103. Taiho Pharmaceutical Colorectal Cancer Drugs Product Offerings
Table 104. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Taiho Pharmaceutical Key News & Latest Developments
Table 106. Vaccinogen Company Summary
Table 107. Vaccinogen Colorectal Cancer Drugs Product Offerings
Table 108. Vaccinogen Colorectal Cancer Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Vaccinogen Key News & Latest Developments
Table 110. Colorectal Cancer Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 111. Global Colorectal Cancer Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Colorectal Cancer Drugs Production by Region, 2018-2023 (Units)
Table 113. Global Colorectal Cancer Drugs Production by Region, 2024-2030 (Units)
Table 114. Colorectal Cancer Drugs Market Opportunities & Trends in Global Market
Table 115. Colorectal Cancer Drugs Market Drivers in Global Market
Table 116. Colorectal Cancer Drugs Market Restraints in Global Market
Table 117. Colorectal Cancer Drugs Raw Materials
Table 118. Colorectal Cancer Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Colorectal Cancer Drugs Downstream
Table 120. Colorectal Cancer Drugs Downstream Clients in Global Market
Table 121. Colorectal Cancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Colorectal Cancer Drugs Segment by Type in 2022
Figure 2. Colorectal Cancer Drugs Segment by Application in 2022
Figure 3. Global Colorectal Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Colorectal Cancer Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Colorectal Cancer Drugs Sales in Global Market: 2018-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Colorectal Cancer Drugs Revenue in 2022
Figure 9. By Type - Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Colorectal Cancer Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Colorectal Cancer Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Colorectal Cancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Colorectal Cancer Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 23. US Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 28. Germany Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 37. China Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Colorectal Cancer Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Colorectal Cancer Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Colorectal Cancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Colorectal Cancer Drugs Production Capacity (Units), 2018-2030
Figure 53. The Percentage of Production Colorectal Cancer Drugs by Region, 2022 VS 2030
Figure 54. Colorectal Cancer Drugs Industry Value Chain
Figure 55. Marketing Channels
